#USA #Los Angeles #GenScript #DNA Storage #Mimulus

Mimulus and GenScript: A Partnership for a Sustainable Future

In an era where data storage is becoming increasingly burdensome due to soaring volumes, two biotechnology companies, Mimulus Corp and GenScript Biotech Corporation, have announced a groundbreaking collaboration aimed at revolutionizing how we archive data. This partnership is centered around the development of a pioneering zero-watt molecular archive system intended for the AI era, aptly named the 'Forever Archive'.

Addressing the Data Storage Crisis

As we stand on the brink of a data explosion projected to reach a staggering 200 zettabytes by 2030, the existing methods of data storage—primarily reliant on magnetic tapes and spinning disks—are proving to be less viable. These legacy systems not only consume substantial amounts of power but are also susceptible to data corruption and costly migrations. Mimulus and GenScript’s collaboration seeks to tackle these challenges by leveraging Mimulus's Molecular Archive Technology™ with GenScript's superior DNA synthesis capabilities.

What is Molecular Archive Technology™?

Mimulus Corp has developed a unique archival technology which allows data to be stored using DNA. One of the primary assets of this technology is the Glacier Data Storage Cards™, which are compact credit card-sized devices that require zero power, no cooling, and demand no ongoing maintenance. When integrated into data storage infrastructures, these devices optimally liberate power resources currently allocated to traditional hard drives, unlocking essential energy for high-value AI computations.

The Vision of a Sustainable Future

Sherry Shao, the Rotating CEO of GenScript, emphasizes that significant breakthroughs in any field are often built on strong foundational infrastructure. She believes that achieving viable DNA data storage can only materialize through high-throughput synthesis operations that will be prompted through their partnership with Mimulus. By industrializing DNA synthesis, GenScript aims to support the mass production of Glacier Cards and propel this revolutionary data storage method into a commercially viable reality.

Under the terms of their collaboration, GenScript will utilize its validated manufacturing prowess to implement high-throughput DNA synthesis, facilitating unprecedented scalability. Meanwhile, Mimulus retains the rights for exclusive licensing of specific GenScript technologies pertinent to digital DNA storage, with clear performance milestones outlined.

Remarkable Benefits for the Data Center Industry

This strategic partnership promises various immediate and long-term benefits:

1. Power Reallocation: By decoupling archival storage from data centers, Glacier Data Storage Cards™ allow operators to reclaim an estimated 7.5 megawatts of power currently consumed by conventional data storage methods. This critical power can then be redirected towards enhancing AI computational capabilities.

2. Data Permanence: With an expected durability spanning centuries, Molecular Archive Technology™ eliminates issues related to data migration and hardware refresh cycles. This ensures a corruption-free data retention process while significantly lowering operational costs by over 95%.

3. Environmental Impact: The innovative approach will ultimately decarbonize data centers, freeing them from the heavy carbon footprint associated with traditional power-hungry systems. A single Glacier Card can replace hundreds of thousands of conventional hard drives, directly contributing to a reduction in physical infrastructure and energy demands.

Future Outlook

Mimulus aims to deploy Glacier Data Storage Cards™ to various enterprises, and engagements are underway to develop integrated manufacturing processes along with industry-standard compatibility for seamless transitions in data centers. By the end of the decade, both companies target to achieve hyperscale production, setting the stage for a radical new chapter in data storage technology. The future of data storage is molecular, and with this partnership, it is inching closer to reality.

About Mimulus Corp

Mimulus is leading the charge in inventing economically and physically sustainable archival solutions designed for the digital age. Utilizing Molecular Archive Technology™, they provide innovative DNA-based storage that meets the modern challenges of data retention and energy efficiency.

About GenScript Biotech Corporation

Established in 2002, GenScript focuses on accelerating advancements in biotechnology and healthcare, aiming to create transformative solutions for researchers across the globe. With over 6,100 employees and a commitment to making the world healthier through biotechnology, GenScript continues to prove its value as a trusted partner in the industry.

For more information on their pioneering efforts, visit Mimulus.